-
MedCity News - Fri Nov 6, 10:04 am ET
CLEVELAND, Ohio -- Athersys Inc. continued enrollments during the third quarter in safety and efficacy trials of its adult stem cell therapy, MultiStem, for heart attack patients and those who run the risk of rejecting bone marrow transplants. At the same time, the clinical-stage biopharmaceutical company looked for money for a third trial involving stroke patients. "We believe MultiStem ...
-
AFP via Yahoo! News - Tue Nov 10, 6:39 am ET
Human embryonic stem cells may one day be used to help people recover abilities to learn and remember that are lost after radiation treatment for brain tumors, experiments on rats suggest.
-
BioresearchOnline - Wed Nov 4, 9:27 am ET
The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the major trends in the global stem cell market.
-
The Scientist - Wed Nov 4, 1:22 pm ET
California's stem cell funding agency giveth and it taketh away
-
redOrbit - Thu Nov 5, 2:18 pm ET
Scientists in Belgium have successfully differentiated human embryonic stem cells (hESC) into major cell types of lung epithelial tissue using a convenient air-liquid interface.
-
CNW Group via Yahoo! Finance - Mon Nov 9, 7:44 pm ET
Orcrist Bio Inc. a biotechnology company developing stem cell-mobilizing pharmaceuticals, congratulates Dr. Linda Pilarski on her receipt of the 2009 ASTech Foundation Outstanding Leadership in Alberta Technology Award.
-
PR Newswire via Yahoo! Finance - Fri Nov 6, 5:00 am ET
Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed shareholder questions about its new laboratory in Las Vegas, and its recently refiled S1 with the SEC, in an interview of Matthew Schissler, founder and CEO, by ...
-
The State News - Tue Nov 3, 9:53 pm ET
MSU researchers are concerned regulations on embryonic stem cell research proposed in a Michigan Senate Committee would interfere with their progress.
-
Business Wire via Yahoo! Finance - Wed Nov 4, 5:00 am ET
SAN DIEGO----Entest BioMedical announced today it has filed a second patent application in the area of Chronic Obstructive Pulmonary Disease . This new patent application builds upon the Company’s previously filed COPD patent application and involves the use of photoceutical devices to target stem cells toward areas impacted by COPD in the lungs.
-
GenomeWeb News - Tue Nov 10, 9:16 am ET
An article looks at how state stem cell funding in California will pan out as the CIRM is about to start doling out major awards for building renovations at state campuses and newly created institutions like the San Diego Consortium for Regenerative Medicine.
-
Fox News - Mon Nov 9, 12:38 pm ET
Chloe Levine had a stroke in utero, resulting in cerebral palsy. But an infusion of her own stem cells changed all that.
-
UC Newsroom - Tue Nov 3, 3:22 pm ET
SACRAMENTO — Four UC Davis stem cell experts will give brief presentations on stem cell research followed by a question-and-answer session during a community forum on Wednesday, Nov. 4, from 6 to 7:30 p.m. at the UC Davis MIND Institute, 2825 50th St., Sacramento.
-
Marketwire - Tue Nov 3, 10:10 am ET
Financing to Provide Resources for Ongoing Development of Stem Cell Products and Research Initiatives
-
redOrbit - Mon Nov 9, 5:20 pm ET
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme –preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.The research team from Cincinnati Children's Hospital Medical Center reports its preclinical laboratory results ...
-
Forbes - Thu Nov 5, 4:40 pm ET
Study findings may lead to way to prevent this cause of death in people